161 related articles for article (PubMed ID: 7710909)
1. The role of protein kinase C in multidrug resistance.
O'Brian CA; Ward NE; Gravitt KR; Fan D
Cancer Treat Res; 1994; 73():41-55. PubMed ID: 7710909
[No Abstract] [Full Text] [Related]
2. Clinical reversal of multidrug resistance.
Sikic BI; Fisher GA; Lum BL; Brophy NA; Yahanda AM; Adler KM; Halsey J
Cancer Treat Res; 1994; 73():149-65. PubMed ID: 7710904
[No Abstract] [Full Text] [Related]
3. In vitro models of multiple drug resistance.
Greenberger LM; Cohen D; Horwitz SB
Cancer Treat Res; 1994; 73():69-106. PubMed ID: 7710911
[No Abstract] [Full Text] [Related]
4. In vivo models of P-glycoprotein-mediated multidrug resistance.
Gottesman MM; Mickisch GH; Pastan I
Cancer Treat Res; 1994; 73():107-28. PubMed ID: 7710902
[No Abstract] [Full Text] [Related]
5. Biology of the multidrug resistance-associated protein, MRP.
Loe DW; Deeley RG; Cole SP
Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
[No Abstract] [Full Text] [Related]
6. Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants.
Pirity M; Hevér-Szabó A; Venetianer A
Cytotechnology; 1996; 19(3):207-14. PubMed ID: 8862008
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein--a mediator of multidrug resistance in tumour cells.
Germann UA
Eur J Cancer; 1996 Jun; 32A(6):927-44. PubMed ID: 8763334
[No Abstract] [Full Text] [Related]
9. Transporter molecules in multidrug resistance.
Scheper RJ; Scheffer GL; Flens MJ; van der Valk P; Broxterman HJ; Izquierdo MA
Cytotechnology; 1996; 19(3):187-90. PubMed ID: 8862005
[No Abstract] [Full Text] [Related]
10. Role of gene amplification in drug resistance.
Schoenlein PV
Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
[No Abstract] [Full Text] [Related]
11. Unanswered questions about multidrug resistance.
Beck WT
Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
[No Abstract] [Full Text] [Related]
12. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
14. Circumvention of P-glycoprotein-mediated multiple drug resistance by phosphorylation modulators is independent of protein kinases.
Smith CD; Zilfou JT
J Biol Chem; 1995 Nov; 270(47):28145-52. PubMed ID: 7499304
[TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative.
Méndez-Vidal C; Quesada AR
Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in human cancer.
Goldstein LJ; Pastan I; Gottesman MM
Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
[No Abstract] [Full Text] [Related]
17. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of multidrug resistance.
Herzog CE; Bates SE
Cancer Treat Res; 1994; 73():129-47. PubMed ID: 7710903
[No Abstract] [Full Text] [Related]
19. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]